adenosine 2',5'-diphosphate has been researched along with theophylline in 1 studies
Studies (adenosine 2',5'-diphosphate) | Trials (adenosine 2',5'-diphosphate) | Recent Studies (post-2010) (adenosine 2',5'-diphosphate) | Studies (theophylline) | Trials (theophylline) | Recent Studies (post-2010) (theophylline) |
---|---|---|---|---|---|
29 | 0 | 2 | 20,076 | 1,612 | 1,383 |
Protein | Taxonomy | adenosine 2',5'-diphosphate (IC50) | theophylline (IC50) |
---|---|---|---|
Adenosine receptor A1 | Bos taurus (cattle) | 2.43 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boeynaems, JM; Communi, D; Robaye, B | 1 |
1 other study(ies) available for adenosine 2',5'-diphosphate and theophylline
Article | Year |
---|---|
Pharmacological characterization of the human P2Y11 receptor.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; CHO Cells; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Inositol 1,4,5-Trisphosphate; Phosphoadenosine Phosphosulfate; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Recombinant Fusion Proteins; Suramin; Theophylline; Thionucleotides; Time Factors; Triazines; Tumor Cells, Cultured | 1999 |